-
The Many Faces of Patient AdvocacyAdvocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
Focusing on the FundamentalsNational Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
-
A Response to RoadblocksThe Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
-
Supporting SurvivorsPanel of experts discuss survivorship challenges and potential areas for study.
by Marci A. Landsmann
-
A New Type of Drug ApprovalAt the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.
by Kate Yandell
-
Cancer Researchers Offer Reasons for OptimismCancer researchers and patient advocates spoke about progress against cancer at a public education forum sponsored by the American Association for Cancer Research.
by Kevin McLaughlin
-
The Evolving Role of Patient AdvocacyAACR’s Scientist↔Survivor Program marks a milestone as patient advocates continue to shape research and policy.
by Marci A. Landsmann
-
An Advocate’s Guide to Attending Scientific MeetingsTwo graduates of the AACR Scientist↔Survivor Program share tips for getting the most out of large scientific conferences.
by Bob Riter and Carole Baas
-
Policy Matters
Forcing Big Tobacco to Tell the TruthA judge orders tobacco companies to come clean about the dangers of their products after decades of deception.
by Roy S. Herbst, MD, PhD
-
Forward Look
Tobacco Ads Admit Cigarettes Cause CancerCBS, ABC and NBC are airing advertisements that acknowledge the link between cigarettes and cancer.
by Sue Rochman
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona
-
Ultraproccessed Foods and Cancer RiskThe idea that ultraprocessed foods are associated with increased risk of metabolic and cardiovascular diseases is well supported, but what does the evidence reveal about these foods and cancer?
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
